vs
摩托罗拉系统(ISSC)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
摩托罗拉系统的季度营收约是STANDARD BIOTOOLS INC.的1.1倍($21.8M vs $19.6M),摩托罗拉系统净利率更高(18.6% vs -177.4%,领先196.0%),摩托罗拉系统同比增速更快(36.6% vs -11.5%),摩托罗拉系统自由现金流更多($7.0M vs $-23.1M),过去两年摩托罗拉系统的营收复合增速更高(42.5% vs -12.2%)
摩托罗拉系统是一家美国科技企业,专注于研发供应安全防护相关产品与服务,总部位于伊利诺伊州芝加哥。公司主营关键通信、视频安防与指挥中心技术,相关产品与服务面向公共安全机构及各类企业。公司于2011年从原摩托罗拉拆分而来,是原摩托罗拉的合法继承主体,原摩托罗拉手机业务拆分后成为摩托罗拉移动。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
ISSC vs LAB — 直观对比
营收规模更大
ISSC
是对方的1.1倍
$19.6M
营收增速更快
ISSC
高出48.0%
-11.5%
净利率更高
ISSC
高出196.0%
-177.4%
自由现金流更多
ISSC
多$30.1M
$-23.1M
两年增速更快
ISSC
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $21.8M | $19.6M |
| 净利润 | $4.1M | $-34.7M |
| 毛利率 | 54.5% | 48.5% |
| 营业利润率 | 28.9% | -168.5% |
| 净利率 | 18.6% | -177.4% |
| 营收同比 | 36.6% | -11.5% |
| 净利润同比 | 451.4% | -28.8% |
| 每股收益(稀释后) | $0.22 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ISSC
LAB
| Q4 25 | $21.8M | — | ||
| Q3 25 | $22.2M | $19.6M | ||
| Q2 25 | $24.1M | $21.8M | ||
| Q1 25 | $21.9M | $40.8M | ||
| Q4 24 | $16.0M | — | ||
| Q3 24 | $15.4M | $22.1M | ||
| Q2 24 | $11.8M | $22.5M | ||
| Q1 24 | $10.7M | $45.5M |
净利润
ISSC
LAB
| Q4 25 | $4.1M | — | ||
| Q3 25 | $7.1M | $-34.7M | ||
| Q2 25 | $2.4M | $-33.5M | ||
| Q1 25 | $5.3M | $-26.0M | ||
| Q4 24 | $736.2K | — | ||
| Q3 24 | $3.2M | $-26.9M | ||
| Q2 24 | $1.6M | $-45.7M | ||
| Q1 24 | $1.2M | $-32.2M |
毛利率
ISSC
LAB
| Q4 25 | 54.5% | — | ||
| Q3 25 | 63.2% | 48.5% | ||
| Q2 25 | 35.5% | 48.8% | ||
| Q1 25 | 51.4% | 48.4% | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 55.4% | 54.9% | ||
| Q2 24 | 53.4% | 46.1% | ||
| Q1 24 | 52.0% | 53.1% |
营业利润率
ISSC
LAB
| Q4 25 | 28.9% | — | ||
| Q3 25 | 37.0% | -168.5% | ||
| Q2 25 | 14.6% | -118.1% | ||
| Q1 25 | 31.8% | -80.8% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 28.4% | -120.9% | ||
| Q2 24 | 17.3% | -134.5% | ||
| Q1 24 | 15.3% | -132.2% |
净利率
ISSC
LAB
| Q4 25 | 18.6% | — | ||
| Q3 25 | 32.0% | -177.4% | ||
| Q2 25 | 10.1% | -153.7% | ||
| Q1 25 | 24.3% | -63.8% | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 20.7% | -122.0% | ||
| Q2 24 | 13.2% | -203.3% | ||
| Q1 24 | 11.3% | -70.6% |
每股收益(稀释后)
ISSC
LAB
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.40 | $-0.09 | ||
| Q2 25 | $0.14 | $-0.09 | ||
| Q1 25 | $0.30 | $-0.07 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.18 | $-0.07 | ||
| Q2 24 | $0.09 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.3M | $129.4M |
| 总债务越低越好 | $23.8M | — |
| 股东权益账面价值 | $68.7M | $399.7M |
| 总资产 | $109.9M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势,按日历期对齐
现金及短期投资
ISSC
LAB
| Q4 25 | $8.3M | — | ||
| Q3 25 | $2.7M | $129.4M | ||
| Q2 25 | $601.8K | $158.6M | ||
| Q1 25 | $1.2M | $150.9M | ||
| Q4 24 | $604.6K | — | ||
| Q3 24 | $539.0K | $210.6M | ||
| Q2 24 | $521.0K | $269.8M | ||
| Q1 24 | $574.1K | $287.1M |
总债务
ISSC
LAB
| Q4 25 | $23.8M | — | ||
| Q3 25 | $24.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
ISSC
LAB
| Q4 25 | $68.7M | — | ||
| Q3 25 | $64.6M | $399.7M | ||
| Q2 25 | $56.8M | $424.5M | ||
| Q1 25 | $53.5M | $454.6M | ||
| Q4 24 | $47.8M | — | ||
| Q3 24 | $46.6M | $489.3M | ||
| Q2 24 | $43.2M | $510.3M | ||
| Q1 24 | $41.4M | $577.3M |
总资产
ISSC
LAB
| Q4 25 | $109.9M | — | ||
| Q3 25 | $103.4M | $539.6M | ||
| Q2 25 | $91.8M | $557.0M | ||
| Q1 25 | $89.9M | $579.6M | ||
| Q4 24 | $81.3M | — | ||
| Q3 24 | $82.4M | $681.5M | ||
| Q2 24 | $59.8M | $708.7M | ||
| Q1 24 | $57.6M | $777.7M |
负债/权益比
ISSC
LAB
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $8.2M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $-23.1M |
| 自由现金流率自由现金流/营收 | 32.3% | -118.1% |
| 资本支出强度资本支出/营收 | 5.1% | 4.5% |
| 现金转化率经营现金流/净利润 | 2.01× | — |
| 过去12个月自由现金流最近4个季度 | $12.3M | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
ISSC
LAB
| Q4 25 | $8.2M | — | ||
| Q3 25 | $3.0M | $-22.2M | ||
| Q2 25 | $7.2M | $-20.7M | ||
| Q1 25 | $1.3M | $-30.3M | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $445.3K | $-27.9M | ||
| Q2 24 | $934.1K | $-39.0M | ||
| Q1 24 | $201.1K | $-62.5M |
自由现金流
ISSC
LAB
| Q4 25 | $7.0M | — | ||
| Q3 25 | $2.0M | $-23.1M | ||
| Q2 25 | $3.5M | $-22.6M | ||
| Q1 25 | $-267.7K | $-35.3M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $299.5K | $-30.1M | ||
| Q2 24 | $730.8K | $-41.0M | ||
| Q1 24 | $75.4K | $-63.3M |
自由现金流率
ISSC
LAB
| Q4 25 | 32.3% | — | ||
| Q3 25 | 8.8% | -118.1% | ||
| Q2 25 | 14.6% | -103.6% | ||
| Q1 25 | -1.2% | -86.6% | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 1.9% | -136.4% | ||
| Q2 24 | 6.2% | -182.2% | ||
| Q1 24 | 0.7% | -138.9% |
资本支出强度
ISSC
LAB
| Q4 25 | 5.1% | — | ||
| Q3 25 | 4.5% | 4.5% | ||
| Q2 25 | 15.3% | 8.7% | ||
| Q1 25 | 7.1% | 12.4% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.9% | 10.2% | ||
| Q2 24 | 1.7% | 8.6% | ||
| Q1 24 | 1.2% | 1.7% |
现金转化率
ISSC
LAB
| Q4 25 | 2.01× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 2.95× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 2.50× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 0.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISSC
| Products | $13.6M | 62% |
| Services | $8.2M | 38% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |